High glycemic variability is associated with a reduced T cell cytokine response to influenza A virus

Authors:

• Tong, Marcus Z.W.
• Hulme, Katina D.
• Law, Soi Cheng
• Noye, Ellesandra
• Dorey, Emily S.
• Chew, Keng Yih
• Rowntree, Louise C.
• van de Sandt, Carolien E.
• Kedzierska, Katherine
• Goeijenbier, Marco
• Ronacher, Katharina
• Alzaid, Fawaz
• Julla, Jean-Baptiste
• Riveline, Jean-Pierre
• Lineburg, Katie E.
• Smith, Corey
• Grant, Emma J.
• Gras, Stephanie
• Gallo, Linda A.
• Barrett, Helen L.
• Short, Kirsty R.

Details:

iScience, Volume 27, Issue 11, 2024-11-15

Article Link: Click here

Diabetes mellitus significantly increases the risk of severe respiratory virus disease like influenza and COVID-19. Early evidence suggests that this susceptibility to respiratory viral disease is driven by glycemic variability, rather than average blood glucose levels. Here, we use blood samples and constant glucose monitoring (CGM) data obtained from people living with type 1 diabetes (T1D) to determine the effects of glycemic variability on the ex vivo T cell response to influenza virus. We show that high glycemic variability in participants living with T1D is associated with a reduced proportion of CD8+CD107a−IFNγ−MIP1β−TNF+ T cells in response to stimulation with influenza virus and an influenza virus peptide pool. Thus, this study provides evidence that glycemic variability affects the ex vivo T cell response to respiratory viruses. These data suggest that monitoring glycemic variability may have important implications in understanding the antiviral immune response in people with diabetes.